58.82MMarket Cap-281P/E (TTM)
0.730High0.660Low296.13KVolume0.710Open0.700Pre Close203.84KTurnover0.50%Turnover RatioLossP/E (Static)88.85MShares4.12052wk High0.70P/B39.43MFloat Cap0.66052wk Low--Dividend TTM59.57MShs Float157.980Historical High--Div YieldTTM10.00%Amplitude0.660Historical Low0.688Avg Price1Lot Size
Allakos Stock Forum
Is this stock going to die ?
Allakos Announces Positive Results From Its Ongoing Phase 1 Trial of Ak006 in Healthy Volunteers, With Ak006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos has announced positive results from the Phase 1 trial of AK006, a Siglec-6 monoclonal antibody being developed to treat mast cell-driven diseases. The drug demonstrated high receptor occupancy on mast cells and a favorable safety profile, with no serious adverse events. Health...
SEC announcement
·
01/29 17:30
No comment yet